C 36 H 30 Cl 2 NP 2 Re,monoclinic, I2/a (no.15), a =15.5631(4)Å, b=9.5180(3) Å, c =22.0872(9)Å,b=103.237(1)°, V =3184.9 Å 3 , Z =4,R gt (F) =0.0203, wR ref (F 2 ) =0.0419, T =200 K.
Source of materialThec ompound has been already reported [3].C rystals suitable for the diffraction study were obtained upon recrystallization of the compound from boiling toluene.
Experimental detailsCarbon-bound Hatomswere placed in calculated positions (C-H 0.95 Å) and were included in the refinementinthe riding model approximation, with U iso (H) setto1.2U eq (C).
DiscussionNext to cardiovascular diseases, cancer has become one of the main fatal diseases in industrialized countries. Apart from classical surgery,chemo-and radiotherapeutic treatments have entered the arsenal of possible cures for certain types of cancer. All methods, however, suffer from their own set of problematic sideeffects and, as aconsequence, the development of radiopharmaceuticals -combining the advantages of chemotherapy as well as radiation methods while at the sametimeavoiding their unique respectiveundesiredside-effects -has been atopic of research [1,2].T ailoring andf ine-tuning of thee nvisionedr adiopharmaceuticals' properties such as lipophilicityand,inparticular, inertness is of paramountimportancewithrespect to possible future in vivo applications in contemporary medicine and requires sound knowledge about structural parameters of the ligands applied if a more heuristic approach in the synthesis is to triumph over pure trial-and-error as it is encountered in this specific field of coordination chemistry up to the present day. In addition, the spatial requirements of pharmaceuticalsa re of importance as this factor influences on their interaction with enzymatic systems and, as a consequence,t he pathway andr ateo fc onjugation, functionalizationand secretionfrom the body. At thebeginning of astudy aboutnitrido-supported rhenium(V) coordination compounds the starting material was chosen as aversatile starting point for synthesizing the desired compounds. The molecular and crystal structureofthis starting material have been reported once already [3], however, at room temperature and without the localization of hydrogen atoms. As this is an unacceptable starting point for the intended study, the crystal structure of the starting compound was redeterminedtoallow for the direct comparison of metrical parameters.S tructurali nformation is also available for ab oraneadduct of thetitle compound [4].The title compound is apentacoordinated rhenium(V) coordination compound. The asymmetric unit contains half amolecule. The coordination sphere around the central atom is constructed by two molecules of PPh 3 ,t wo chlorido and one nitrido ligand. The resulting coordination polyhedron is square-pyramidal but shows ad istortion by 39.2°to-wards at rigonalb ipyramid on the Berry pseudorotation coordinate [5]. The Re-N bond length is found at 1.648(3) Å which is longer than the value of 1.60 Åreported for the structure determination at room temperature with...